MENU
+Compare
MAHLY
Stock ticker: OTC
AS OF
Aug 14 closing price
Price
$17.50
Change
-$0.44 (-2.45%)
Capitalization
3.66B

MAHLY stock forecast, quote, news & analysis

Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers... Show more

MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for MAHLY with price predictions
Aug 28, 2025

Aroon Indicator for MAHLY shows an upward move is likely

MAHLY's Aroon Indicator triggered a bullish signal on August 20, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 141 similar instances where the Aroon Indicator showed a similar pattern. In of the 141 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on August 28, 2025. You may want to consider a long position or call options on MAHLY as a result. In of 53 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for MAHLY moved above the 200-day moving average on August 08, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MAHLY advanced for three days, in of 13 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MAHLY moved out of overbought territory on August 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for MAHLY turned negative on August 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

MAHLY broke above its upper Bollinger Band on August 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MAHLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.863) is normal, around the industry mean (7.748). P/E Ratio (13.345) is within average values for comparable stocks, (24.083). MAHLY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.540). Dividend Yield (0.024) settles around the average of (0.031) among similar stocks. P/S Ratio (0.146) is also within normal values, averaging (141.388).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MAHLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

MAHLY paid dividends on June 18, 2024

Medipal Holdings Corp. MAHLY Stock Dividends
А dividend of $0.19 per share was paid with a record date of June 18, 2024, and an ex-dividend date of March 27, 2024. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 10.21B. The market cap for tickers in the group ranges from 557.05K to 85.41B. MCK holds the highest valuation in this group at 85.41B. The lowest valued company is CNBI at 557.05K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 3%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was -1%. EDAP experienced the highest price growth at 35%, while SNYR experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 37% and the average quarterly volume growth was -69%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 100
Price Growth Rating: 57
SMR Rating: 100
Profit Risk Rating: 85
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
N/A
Address
2-7-15, Yaesu
Phone
+81 335175800
Employees
21731
Web
http://www.medipal.co.jp